Delivery Order SPE2DB24D2205-SPE2DB25FEBVT

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,942,875 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,911.81. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The ultimate completion date for this order is April 17, 2025. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,108,607 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $25,267.75. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $20,933.77, is for the delivery of 4,567,942,222 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,336,595 CIMZIA 2X200 MG/ML syringe kits, with a ceiling value of $28,504.51 and a period of performance through January 17, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,061,425 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,619.32. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,379,479 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a ceiling value of $28,803.46 and is a firm fixed-price, delivery order type contract with a period of performance through August 8, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,357.01 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a specialty pharmaceutical product. The contract has an ultimate completion date of May 25, 2023 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,123,197 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $27,118.73 and a period of performance through May 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,673,289 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a ceiling value of $30,763.22 and a period of performance through March 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $13,495.25 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits. AmerisourceBergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBVT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,830.41, is for the delivery of 4,568,119,270 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 8/3/25, 1:08 AM